Erratum: Predicting clinically significant prostate cancer using DCEMRI habitat descriptors

N. Andres Parra¹, Hong Lu^1,2, Qian Li², Radka Stoyanova³, Alan Pollack³, Sanoj Punnen⁴, Jung Choi⁵, Mahmoud Abdalah¹, Christopher Lopez³, Kenneth Gage⁵, Jong Y. Park⁶, Yamoah Kosj^6,7, Julio M. Pow-Sang⁸, Robert J. Gillies^1,5 and Yoganand Balagurunathan¹

¹ Department of Cancer Physiology, H.L. Moffitt Cancer Center, Tampa, FL, USA
² Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
³ Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA
⁴ Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA
⁵ Department of Radiology, H.L. Moffitt Cancer Center, Tampa, FL, USA
⁶ Department of Cancer Epidemiology, H.L. Moffitt Cancer Center, Tampa, FL, USA
⁷ Department of Radiation Oncology, H.L. Moffitt Cancer Center, Tampa, FL, USA
⁸ Department of Urology, H.L. Moffitt Cancer Center, Tampa, FL, USA

Published: March 12, 2019

This article has been corrected: During production, the author name for this article was given incorrectly. The proper author name is shown below.

N. Andres Parra

Original article: Oncotarget. 2018; 9:37125-37136. DOI: https://doi.org/10.18632/oncotarget.26437.